Gene synthesis in the area of molecular biology has emerged as a novel applicati

Posted by Coherent Market insights on January 4th, 2021

The use of cloned, or genetically engineered, viruses for gene synthesis and assembly is now widespread. This method of creating personalized medicines relies on the expression of genetic information from a transformed host cell without any introduction of a foreign object. The most well-known of these viruses used for expression is the herpes simplex Type II viruses and the reporter viruses. These viruses are transformed with the genetic information for the production of the desired polypeptides and nuclease domains needed for gene synthesis. Although this technology has been successfully applied to generating the insulin molecule in yeast and algae, it is currently not available to create diphosphoglycan, which is the backbone of the ribosome. The future of medicines may hinge on the ability to use the engineered genetic constructions for applications beyond medicine.

Biotechnological companies, private individuals, and the Food and Drug Administration (FDA) are racing to find better ways to utilize genetic resources to address pressing issues surrounding the world's aging population, environmental problems, and the introduction of foreign toxins and allergens into food supplies. In the case of gene synthesis, the key issue is the ability to produce high levels of functional proteins that are needed by the body to maintain cellular function. Cloning is necessary to achieve this goal, but it is still a very complicated procedure that poses great challenges to those working in the field. Thus, gene synthesis is gaining traction in most of the medical research and development field and it will continue to gain attention due to growing healthcare need around the globe.

Read More:

Like it? Share it!

Coherent Market insights

About the Author

Coherent Market insights
Joined: December 12th, 2020
Articles Posted: 119

More by this author